HOLI [Hollysys Automation Technologies] 6-K: (Original Filing)

[Hollysys Automation Technologies Secures Exclusivity Supplier Status of Its Nuclear Non-Safety Product through 10% Divestiture of Its Nuclear JV (“Hollysys” or the “Company”), - Beijing, China – November 23, 2011 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) 0 Dr. Changli Wang, Hollysys Chairman and CEO, commented: “We are very pleased to secure our exclusivity supplier status of our nuclear non-safety]

By | 2016-03-10T09:42:39+00:00 November 23rd, 2011|Categories: Chinese Stocks, HOLI, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 18, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) Identification No.) (IRS Employer 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T20:01:38+00:00 November 23rd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

HOLI [Hollysys Automation Technologies] 6-K: Hollysys Automation Technologies Secures Exclusivity Supplier Status of

[Hollysys Automation Technologies Secures Exclusivity Supplier Status of Its Nuclear Non-Safety Product through 10% Divestiture of Its Nuclear JV (“Hollysys” or the “Company”), - Beijing, China – November 23, 2011 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) 0 Dr. Changli Wang, Hollysys Chairman and CEO, commented: “We are very pleased to secure our exclusivity supplier status of our nuclear non-safety]

By | 2016-03-10T09:45:18+00:00 November 23rd, 2011|Categories: Chinese Stocks, HOLI, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM

[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 18, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) Identification No.) (IRS Employer 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T20:02:27+00:00 November 23rd, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

RCON [Recon Technology] 8-K: (Original Filing)

[BEIJING, Nov. 23, 2011 /PRNewswire-Asia/ -- Recon Technology, Ltd. (Nasdaq: RCON) ("Recon" or the "Company"), a Chinese non-state-owned oilfield services provider, today announced that on November 17, 2011, The Nasdaq OMX Group ("Nasdaq") sent the Company a letter (the "Nasdaq Letter") indicating that, as a result of the Company's failure to file its quarterly report on Form 10-Q for the] [Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 17, 2011, Recon Technology, Ltd (the “Company”) received from The Nasdaq OMX Group (“Nasdaq”) a letter (the “November Nasdaq Letter”) indicating that, as a result of the Company’s failure to file its quarterly report on Form 10-Q for the three]

By | 2016-03-13T07:27:16+00:00 November 23rd, 2011|Categories: Chinese Stocks, RCON, SEC Original|Tags: , , , , , |0 Comments

CISG [CNINSURE] 6-K: (Original Filing)

[IR-131 CNinsure Reports Third Quarter 2011 Unaudited Financial Results GUANGZHOU, November 21, 2011 (GLOBE NEWSWIRE) -- CNinsure Inc., (Nasdaq: CISG), (the “Company” or “CNinsure”), a leading independent insurance intermediary company operating in China, today announced its unaudited financial results for the third quarter ended September 30, 2011.(1) Financial Highlights: Highlights for Third Quarter 2011 · Total net revenues: RMB383.7 million] [FORM 6-K CNINSURE INC. 22/F, Yinhai Building Form 20-F x Form 40-F o o o CNINSURE INC. Form 6-K TABLE OF CONTENTS]

By | 2016-03-29T19:44:09+00:00 November 23rd, 2011|Categories: Chinese Stocks, CISG, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar